BrainStorm Cell Therapeutics
BCLI
#10415
Rank
โ‚ฌ5.28 M
Marketcap
0,48ย โ‚ฌ
Share price
-6.67%
Change (1 day)
-68.69%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) - Cash on Hand

Cash on Hand as of June 2025 : โ‚ฌ0.7 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company has โ‚ฌ0.7 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

BrainStorm Cell Therapeutics - Cash on Hand chart (from 2002 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚ฌ0.17 M-84.72%
2023-12-31โ‚ฌ1.17 M-57.71%
2022-12-31โ‚ฌ2.78 M-85.75%
2021-12-31โ‚ฌ19.5 M-42.78%
2020-12-31โ‚ฌ34.09 M6612.44%
2019-12-31โ‚ฌ0.5 M-91.77%
2018-12-31โ‚ฌ6.17 M-4.47%
2017-12-31โ‚ฌ6.46 M-31.94%
2016-12-31โ‚ฌ9.49 M-34.91%
2015-12-31โ‚ฌ14.59 M107.79%
2014-12-31โ‚ฌ7.02 M176.86%
2013-12-31โ‚ฌ2.53 M-17.88%
2012-12-31โ‚ฌ3.08 M108.61%
2011-12-31โ‚ฌ1.48 M2017.85%
2010-12-31โ‚ฌ0.06 M9917.24%
2009-12-31โ‚ฌ0 M-51.21%
2008-12-31โ‚ฌ0 M-97.57%
2007-12-31โ‚ฌ0.05 M29.53%
2006-12-31โ‚ฌ0.04 M
2006-03-31โ‚ฌ0.24 M-40.61%
2005-03-31โ‚ฌ0.4 M10854.2%
2004-03-31โ‚ฌ0 M-59.67%
2003-03-31โ‚ฌ0 M-77.71%
2002-03-31โ‚ฌ0.04 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Gilead Sciences
GILD
โ‚ฌ6.28 B 891,768.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
โ‚ฌ0.82 B 116,712.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
โ‚ฌ1.05 B 150,020.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ3.38 B 480,531.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚ฌ2.95 M 319.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA